vs
PUMA BIOTECHNOLOGY, INC.(PBYI)与Thermon Group Holdings, Inc.(THR)财务数据对比。点击上方公司名可切换其他公司
Thermon Group Holdings, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的2.0倍($147.3M vs $75.5M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs 9.6%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $13.1M)
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
Thermon Group Holdings是全球专业热管理解决方案供应商,主打伴热系统、加热电缆、温控监测设备及相关安装支持服务,服务油气、化工、发电、食品饮料等核心工业领域,业务覆盖北美、欧洲、亚太、拉美等全球主要市场。
PBYI vs THR — 直观对比
营收规模更大
THR
是对方的2.0倍
$75.5M
营收增速更快
PBYI
高出18.1%
9.6%
自由现金流更多
PBYI
多$1.3M
$13.1M
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $75.5M | $147.3M |
| 净利润 | — | $18.3M |
| 毛利率 | 69.3% | 46.6% |
| 营业利润率 | 22.7% | 18.1% |
| 净利率 | — | 12.4% |
| 营收同比 | 27.7% | 9.6% |
| 净利润同比 | — | -1.3% |
| 每股收益(稀释后) | $0.26 | $0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PBYI
THR
| Q4 25 | $75.5M | $147.3M | ||
| Q3 25 | $54.5M | $131.7M | ||
| Q2 25 | $52.4M | $108.9M | ||
| Q1 25 | $46.0M | — | ||
| Q4 24 | $59.1M | — | ||
| Q3 24 | $80.5M | — | ||
| Q2 24 | $47.1M | — | ||
| Q1 24 | $43.8M | — |
净利润
PBYI
THR
| Q4 25 | — | $18.3M | ||
| Q3 25 | $8.8M | $15.0M | ||
| Q2 25 | $5.9M | $8.6M | ||
| Q1 25 | $3.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | — | ||
| Q2 24 | $-4.5M | — | ||
| Q1 24 | $-4.8M | — |
毛利率
PBYI
THR
| Q4 25 | 69.3% | 46.6% | ||
| Q3 25 | 77.7% | 46.4% | ||
| Q2 25 | 76.5% | 44.1% | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率
PBYI
THR
| Q4 25 | 22.7% | 18.1% | ||
| Q3 25 | 17.6% | 16.4% | ||
| Q2 25 | 12.7% | 10.8% | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 27.4% | — | ||
| Q2 24 | -4.6% | — | ||
| Q1 24 | -5.3% | — |
净利率
PBYI
THR
| Q4 25 | — | 12.4% | ||
| Q3 25 | 16.2% | 11.4% | ||
| Q2 25 | 11.2% | 7.9% | ||
| Q1 25 | 6.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | — | ||
| Q2 24 | -9.6% | — | ||
| Q1 24 | -11.0% | — |
每股收益(稀释后)
PBYI
THR
| Q4 25 | $0.26 | $0.55 | ||
| Q3 25 | $0.17 | $0.45 | ||
| Q2 25 | $0.12 | $0.26 | ||
| Q1 25 | $0.06 | — | ||
| Q4 24 | $0.40 | — | ||
| Q3 24 | $0.41 | — | ||
| Q2 24 | $-0.09 | — | ||
| Q1 24 | $-0.10 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $46.9M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $538.7M |
| 总资产 | $216.3M | $816.7M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势,按日历期对齐
现金及短期投资
PBYI
THR
| Q4 25 | $97.5M | $46.9M | ||
| Q3 25 | $94.4M | $29.7M | ||
| Q2 25 | $96.0M | $36.5M | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $96.8M | — | ||
| Q1 24 | $107.2M | — |
总债务
PBYI
THR
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益
PBYI
THR
| Q4 25 | $130.3M | $538.7M | ||
| Q3 25 | $115.3M | $515.2M | ||
| Q2 25 | $104.7M | $509.3M | ||
| Q1 25 | $97.1M | — | ||
| Q4 24 | $92.1M | — | ||
| Q3 24 | $71.1M | — | ||
| Q2 24 | $48.5M | — | ||
| Q1 24 | $51.0M | — |
总资产
PBYI
THR
| Q4 25 | $216.3M | $816.7M | ||
| Q3 25 | $202.9M | $778.2M | ||
| Q2 25 | $194.9M | $765.3M | ||
| Q1 25 | $196.2M | — | ||
| Q4 24 | $213.3M | — | ||
| Q3 24 | $220.7M | — | ||
| Q2 24 | $205.0M | — | ||
| Q1 24 | $214.1M | — |
负债/权益比
PBYI
THR
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $14.4M | $18.0M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $13.1M |
| 自由现金流率自由现金流/营收 | 19.1% | 8.9% |
| 资本支出强度资本支出/营收 | 0.0% | 3.3% |
| 现金转化率经营现金流/净利润 | — | 0.98× |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势,按日历期对齐
经营现金流
PBYI
THR
| Q4 25 | $14.4M | $18.0M | ||
| Q3 25 | $9.7M | $7.4M | ||
| Q2 25 | $14.1M | $10.7M | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | $11.2M | — |
自由现金流
PBYI
THR
| Q4 25 | $14.4M | $13.1M | ||
| Q3 25 | $9.7M | $4.4M | ||
| Q2 25 | $14.1M | $8.3M | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
自由现金流率
PBYI
THR
| Q4 25 | 19.1% | 8.9% | ||
| Q3 25 | 17.7% | 3.3% | ||
| Q2 25 | 26.8% | 7.6% | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
资本支出强度
PBYI
THR
| Q4 25 | 0.0% | 3.3% | ||
| Q3 25 | 0.0% | 2.3% | ||
| Q2 25 | 0.0% | 2.2% | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率
PBYI
THR
| Q4 25 | — | 0.98× | ||
| Q3 25 | 1.10× | 0.50× | ||
| Q2 25 | 2.41× | 1.25× | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
THR
| Other | $73.7M | 50% |
| Transferred At Point In Time | $56.1M | 38% |
| Transferred Over Time | $17.5M | 12% |